{"id":"https://openalex.org/W6958772541","doi":"https://doi.org/10.6084/m9.figshare.29755813","title":"Additional file 2 of EPHX1 enhances drug resistance to regorafenib by activating the JAK/STAT signaling pathway in hepatocellular carcinoma cell lines","display_name":"Additional file 2 of EPHX1 enhances drug resistance to regorafenib by activating the JAK/STAT signaling pathway in hepatocellular carcinoma cell lines","publication_year":2025,"publication_date":"2025-01-01","ids":{"openalex":"https://openalex.org/W6958772541","doi":"https://doi.org/10.6084/m9.figshare.29755813"},"language":"en","primary_location":{"id":"pmh:oai:figshare.com:article/29755813","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Additional_file_2_of_EPHX1_enhances_drug_resistance_to_regorafenib_by_activating_the_JAK_STAT_signaling_pathway_in_hepatocellular_carcinoma_cell_lines/29755813","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Text"},"volume":null,"type":"article","indexed_in":["datacite"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://figshare.com/articles/journal_contribution/Additional_file_2_of_EPHX1_enhances_drug_resistance_to_regorafenib_by_activating_the_JAK_STAT_signaling_pathway_in_hepatocellular_carcinoma_cell_lines/29755813","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5143810385","display_name":"Bin Xu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I191996457","display_name":"Dalian Medical University","ror":"https://ror.org/04c8eg608","country_code":"CN","type":"education","lineage":["https://openalex.org/I191996457"]},{"id":"https://openalex.org/I4210100868","display_name":"Second Affiliated Hospital of Dalian Medical University","ror":"https://ror.org/012f2cn18","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210100868"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xu, Bin","raw_affiliation_strings":["Dalian Medical University","Second Affiliated Hospital of Dalian Medical University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dalian Medical University","institution_ids":["https://openalex.org/I191996457"]},{"raw_affiliation_string":"Second Affiliated Hospital of Dalian Medical University","institution_ids":["https://openalex.org/I4210100868"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030224527","display_name":"Xiangnan Liang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I191996457","display_name":"Dalian Medical University","ror":"https://ror.org/04c8eg608","country_code":"CN","type":"education","lineage":["https://openalex.org/I191996457"]},{"id":"https://openalex.org/I4210100868","display_name":"Second Affiliated Hospital of Dalian Medical University","ror":"https://ror.org/012f2cn18","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210100868"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Liang, Xiangnan","raw_affiliation_strings":["Dalian Medical University","Second Affiliated Hospital of Dalian Medical University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dalian Medical University","institution_ids":["https://openalex.org/I191996457"]},{"raw_affiliation_string":"Second Affiliated Hospital of Dalian Medical University","institution_ids":["https://openalex.org/I4210100868"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039751198","display_name":"Wuguang Liu","orcid":"https://orcid.org/0000-0003-1180-9529","observed_orcids":["https://orcid.org/0000-0003-1180-9529"]},"institutions":[{"id":"https://openalex.org/I191996457","display_name":"Dalian Medical University","ror":"https://ror.org/04c8eg608","country_code":"CN","type":"education","lineage":["https://openalex.org/I191996457"]},{"id":"https://openalex.org/I4210100868","display_name":"Second Affiliated Hospital of Dalian Medical University","ror":"https://ror.org/012f2cn18","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210100868"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Liu, Wuguang","raw_affiliation_strings":["Dalian Medical University","Second Affiliated Hospital of Dalian Medical University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dalian Medical University","institution_ids":["https://openalex.org/I191996457"]},{"raw_affiliation_string":"Second Affiliated Hospital of Dalian Medical University","institution_ids":["https://openalex.org/I4210100868"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Wu, BaiTong","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210100868","display_name":"Second Affiliated Hospital of Dalian Medical University","ror":"https://ror.org/012f2cn18","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210100868"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Wu, BaiTong","raw_affiliation_strings":["Second Affiliated Hospital of Dalian Medical University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Second Affiliated Hospital of Dalian Medical University","institution_ids":["https://openalex.org/I4210100868"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Wang, Qiuxiang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I191996457","display_name":"Dalian Medical University","ror":"https://ror.org/04c8eg608","country_code":"CN","type":"education","lineage":["https://openalex.org/I191996457"]},{"id":"https://openalex.org/I4210100868","display_name":"Second Affiliated Hospital of Dalian Medical University","ror":"https://ror.org/012f2cn18","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210100868"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Wang, Qiuxiang","raw_affiliation_strings":["Dalian Medical University","Second Affiliated Hospital of Dalian Medical University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dalian Medical University","institution_ids":["https://openalex.org/I191996457"]},{"raw_affiliation_string":"Second Affiliated Hospital of Dalian Medical University","institution_ids":["https://openalex.org/I4210100868"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Kai, Gong","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I191996457","display_name":"Dalian Medical University","ror":"https://ror.org/04c8eg608","country_code":"CN","type":"education","lineage":["https://openalex.org/I191996457"]},{"id":"https://openalex.org/I4210100868","display_name":"Second Affiliated Hospital of Dalian Medical University","ror":"https://ror.org/012f2cn18","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210100868"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Kai, Gong","raw_affiliation_strings":["Dalian Medical University","Second Affiliated Hospital of Dalian Medical University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dalian Medical University","institution_ids":["https://openalex.org/I191996457"]},{"raw_affiliation_string":"Second Affiliated Hospital of Dalian Medical University","institution_ids":["https://openalex.org/I4210100868"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102964171","display_name":"Chun Han","orcid":"https://orcid.org/0000-0003-4925-0388","observed_orcids":["https://orcid.org/0000-0003-4925-0388"]},"institutions":[{"id":"https://openalex.org/I191996457","display_name":"Dalian Medical University","ror":"https://ror.org/04c8eg608","country_code":"CN","type":"education","lineage":["https://openalex.org/I191996457"]},{"id":"https://openalex.org/I4210100868","display_name":"Second Affiliated Hospital of Dalian Medical University","ror":"https://ror.org/012f2cn18","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210100868"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Han, Chun","raw_affiliation_strings":["Dalian Medical University","Second Affiliated Hospital of Dalian Medical University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dalian Medical University","institution_ids":["https://openalex.org/I191996457"]},{"raw_affiliation_string":"Second Affiliated Hospital of Dalian Medical University","institution_ids":["https://openalex.org/I4210100868"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078839250","display_name":"Binwen Sun","orcid":"https://orcid.org/0000-0001-5360-4439","observed_orcids":["https://orcid.org/0000-0001-5360-4439"]},"institutions":[{"id":"https://openalex.org/I191996457","display_name":"Dalian Medical University","ror":"https://ror.org/04c8eg608","country_code":"CN","type":"education","lineage":["https://openalex.org/I191996457"]},{"id":"https://openalex.org/I4210100868","display_name":"Second Affiliated Hospital of Dalian Medical University","ror":"https://ror.org/012f2cn18","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210100868"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Sun, Binwen","raw_affiliation_strings":["Dalian Medical University","Second Affiliated Hospital of Dalian Medical University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dalian Medical University","institution_ids":["https://openalex.org/I191996457"]},{"raw_affiliation_string":"Second Affiliated Hospital of Dalian Medical University","institution_ids":["https://openalex.org/I4210100868"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Dong, Bing","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I191996457","display_name":"Dalian Medical University","ror":"https://ror.org/04c8eg608","country_code":"CN","type":"education","lineage":["https://openalex.org/I191996457"]},{"id":"https://openalex.org/I4210100868","display_name":"Second Affiliated Hospital of Dalian Medical University","ror":"https://ror.org/012f2cn18","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210100868"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Dong, Bing","raw_affiliation_strings":["Dalian Medical University","Second Affiliated Hospital of Dalian Medical University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dalian Medical University","institution_ids":["https://openalex.org/I191996457"]},{"raw_affiliation_string":"Second Affiliated Hospital of Dalian Medical University","institution_ids":["https://openalex.org/I4210100868"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Dong, Chengyong","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I191996457","display_name":"Dalian Medical University","ror":"https://ror.org/04c8eg608","country_code":"CN","type":"education","lineage":["https://openalex.org/I191996457"]},{"id":"https://openalex.org/I4210100868","display_name":"Second Affiliated Hospital of Dalian Medical University","ror":"https://ror.org/012f2cn18","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210100868"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Dong, Chengyong","raw_affiliation_strings":["Dalian Medical University","Second Affiliated Hospital of Dalian Medical University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dalian Medical University","institution_ids":["https://openalex.org/I191996457"]},{"raw_affiliation_string":"Second Affiliated Hospital of Dalian Medical University","institution_ids":["https://openalex.org/I4210100868"]}]},{"author_position":"last","author":{"id":null,"display_name":"Wang, Liming","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I191996457","display_name":"Dalian Medical University","ror":"https://ror.org/04c8eg608","country_code":"CN","type":"education","lineage":["https://openalex.org/I191996457"]},{"id":"https://openalex.org/I4210100868","display_name":"Second Affiliated Hospital of Dalian Medical University","ror":"https://ror.org/012f2cn18","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210100868"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Wang, Liming","raw_affiliation_strings":["Dalian Medical University","Second Affiliated Hospital of Dalian Medical University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dalian Medical University","institution_ids":["https://openalex.org/I191996457"]},{"raw_affiliation_string":"Second Affiliated Hospital of Dalian Medical University","institution_ids":["https://openalex.org/I4210100868"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.4351654,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":true,"primary_topic":{"id":"https://openalex.org/T10073","display_name":"Hepatocellular Carcinoma Treatment and Prognosis","score":0.8925999999046326,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10073","display_name":"Hepatocellular Carcinoma Treatment and Prognosis","score":0.8925999999046326,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.018200000748038292,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12910","display_name":"Eicosanoids and Hypertension Pharmacology","score":0.01209999993443489,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ephx1","display_name":"EPHX1","score":1.0},{"id":"https://openalex.org/keywords/regorafenib","display_name":"regorafenib","score":0.9290000200271606},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.996999979019165},{"id":"https://openalex.org/keywords/jak-stat-signaling","display_name":"JAK/STAT signaling","score":0.9760000109672546},{"id":"https://openalex.org/keywords/hepatocellular-carcinoma","display_name":"hepatocellular carcinoma","score":0.9980000257492065},{"id":"https://openalex.org/keywords/hcc-cell-lines","display_name":"HCC cell lines","score":0.9020000100135803},{"id":"https://openalex.org/keywords/ic50","display_name":"IC50","score":0.8679999709129333},{"id":"https://openalex.org/keywords/protein-tyrosine-phosphatase","display_name":"protein tyrosine phosphatase","score":0.652999997138977}],"concepts":[{"id":"https://openalex.org/C2776248978","wikidata":"https://www.wikidata.org/wiki/Q3891664","display_name":"Regorafenib","level":4,"score":0.9509000182151794},{"id":"https://openalex.org/C2778019345","wikidata":"https://www.wikidata.org/wiki/Q1148337","display_name":"Hepatocellular carcinoma","level":2,"score":0.670199990272522},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6237000226974487},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.5924000144004822},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4465999901294708},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.4203000068664551},{"id":"https://openalex.org/C2776415932","wikidata":"https://www.wikidata.org/wiki/Q48743","display_name":"Western blot","level":3,"score":0.4174000024795532},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.40290001034736633},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4009000062942505},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.38920000195503235},{"id":"https://openalex.org/C114851261","wikidata":"https://www.wikidata.org/wiki/Q12147416","display_name":"Drug resistance","level":2,"score":0.38190001249313354},{"id":"https://openalex.org/C85265743","wikidata":"https://www.wikidata.org/wiki/Q885458","display_name":"Blot","level":3,"score":0.36660000681877136},{"id":"https://openalex.org/C2994294914","wikidata":"https://www.wikidata.org/wiki/Q1645075","display_name":"Acquired resistance","level":3,"score":0.3181999921798706},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.2904999852180481},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2784999907016754},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.26649999618530273},{"id":"https://openalex.org/C2777752497","wikidata":"https://www.wikidata.org/wiki/Q286779","display_name":"IC50","level":3,"score":0.25760000944137573}],"mesh":[],"locations_count":3,"locations":[{"id":"pmh:oai:figshare.com:article/29755813","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Additional_file_2_of_EPHX1_enhances_drug_resistance_to_regorafenib_by_activating_the_JAK_STAT_signaling_pathway_in_hepatocellular_carcinoma_cell_lines/29755813","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Text"},{"id":"doi:10.6084/m9.figshare.29755813","doi":"https://doi.org/10.6084/m9.figshare.29755813","is_oa":true,"landing_page_url":"https://doi.org/10.6084/m9.figshare.29755813","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":null,"raw_source_name":null,"raw_type":"JournalArticle"},{"id":"doi:10.6084/m9.figshare.29755813.v1","doi":"https://doi.org/10.6084/m9.figshare.29755813.v1","is_oa":true,"landing_page_url":"https://doi.org/10.6084/m9.figshare.29755813.v1","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":null,"raw_source_name":null,"raw_type":"JournalArticle"}],"best_oa_location":{"id":"pmh:oai:figshare.com:article/29755813","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Additional_file_2_of_EPHX1_enhances_drug_resistance_to_regorafenib_by_activating_the_JAK_STAT_signaling_pathway_in_hepatocellular_carcinoma_cell_lines/29755813","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8560000061988831}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8780039548873901}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":[],"abstract_inverted_index":{"Supplementary":[0,3],"Material":[1],"2:":[2],"Figure":[4],"1:":[5],"Induction":[6],"of":[7,20,39],"Regorafenib":[8,21,47],"resistance":[9],"by":[10,24],"EPHX1":[11,40],"in":[12,27,41],"hepatocarcinoma":[13],"cell":[14,30,44],"lines.":[15,31],"(A)":[16],"The":[17],"IC50":[18],"values":[19],"were":[22],"detected":[23],"CCK-8":[25],"assays":[26],"four":[28,42],"HCC":[29,43],"(B)":[32],"Western":[33],"blot":[34],"analysis":[35],"showed":[36],"the":[37],"levels":[38],"lines":[45],"after":[46],"treatment.":[48],"*":[49],"p":[50,53,56],"<":[51,54,57],"0.05\uff0c**":[52],"0.01\uff0c***":[55],"0.001.":[58]},"counts_by_year":[],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2025-10-10T00:00:00"}